Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Crompton

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene ExpressionMatthew L Hemming, Patrick Bhola, Michael A Loycano, et al.
American Journal of Human Genetics|May 5, 2022
Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genesRiaz Gillani, Sabrina Y Camp, Seunghun Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric <i>NTRK</i> Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823)Theodore W Laetsch, Stephan Voss, Kathleen Ludwig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2023
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupSamuel Abbou, Kelly Klega, Junko Tsuji, et al.
Molecular Cancer Therapeutics|July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress ResponseKathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
JCO Precision Oncology|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN StudyHolly J Roberts, Hannah Comeau, Kelly Klega, et al.
The Journal of Clinical Investigation|November 18, 2014
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesisMichelle Marques Howarth, David Simpson, Siu P Ngok, et al.
Science (New York, N.Y.)|January 2, 2025
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene ExpressionMatthew L Hemming, Patrick Bhola, Michael A Loycano, et al.
American Journal of Human Genetics|May 5, 2022
Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genesRiaz Gillani, Sabrina Y Camp, Seunghun Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric <i>NTRK</i> Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823)Theodore W Laetsch, Stephan Voss, Kathleen Ludwig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2023
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupSamuel Abbou, Kelly Klega, Junko Tsuji, et al.
Molecular Cancer Therapeutics|July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress ResponseKathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
JCO Precision Oncology|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN StudyHolly J Roberts, Hannah Comeau, Kelly Klega, et al.
The Journal of Clinical Investigation|November 18, 2014
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesisMichelle Marques Howarth, David Simpson, Siu P Ngok, et al.
Science (New York, N.Y.)|January 2, 2025
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Pageof 7